Why are African Americans under-represented in medical research studies? Impediments to participation

Ethnicity and Health

Volumn 2, Issue 1-2, 1997, Pages 31-45

  Shavers Hornaday, Vickie L ^a   Lynch, Charles F ^a   Burmeister, Leon F ^a   Torner, James C ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

African Americans; Blacks; Distrust; Ethnicity; Medical research; Minorities; Participation barrier; Recruitment

Indexed keywords

ALIENATION; ARTICLE; ATTITUDE; CLINICAL TRIAL; CULTURAL FACTOR; ETHNIC GROUP; HEALTH CARE ACCESS; HEALTH PRACTITIONER; HISTORY; HUMAN; LANGUAGE ABILITY; MEDICAL RESEARCH; MINORITY GROUP; NEGRO; PERCEPTION; POPULATION RESEARCH; PRIMARY MEDICAL CARE;

EID: 0030761568     PISSN: 13557858     EISSN: None     Source Type: Journal    
DOI: 10.1080/13557858.1997.9961813     Document Type: Article

References (107)

1. Weiss BL & Kupfer DJ. The black patient and research in a community mental health center: where have all the subjects gone? Am J Psychiat 1974; 31: 415-18.
2. El-Sadr W & Capps L. The challenge of minority recruitment in clinical trials for AIDS. JAMA 1992; 267: 954-7.
3. Fauci AS. AIDS - challenges to basic and clinical biomedical research. Acad Med 1989; 64: 115-19.
4. Million-Underwood S, Sanders E & Davis M. Determinants of participation in state-of-the-art cancer prevention, early detection/screening, and treatment trials among African-Americans. Cancer Nurs 1993; 161: 25-33.
5. Thomas CR, Pinto HA, Roach M & Vaughn CB. Participation in clinical trials: is it state-of-the-art treatment for African Americans and other people of color? J Natl Med Assoc 1994; 86: 177-82.
6. Frierson HT & Wyche JH. Addressing the medical researcher/faculty supply: tapping a neglected source. J Natl Med Assoc 1994; 86: 97-9.
7. Goldberg KB & Goldberg P, Eds. Minority accrual low in prevention trials: NCI plans programs to boost enrollment. Can Lett 1996; 22: 1-4.
8. VA Cooperative Study Group on Antihypertensive Agents. Low-dose captopril for the treatment of mild to moderate hypertension. Arch Intern Med 1984; 144: 1947-53.
9. Freier PA, Wollam GL, Hall WD, Unger DJ, Douglas MB & Bain RP. Blood pressure plasma volume, and catecholamine levels during enalapril therapy in blacks with hypertension. Clin Pharmcol Ther 1984; 36: 731-7.
10. Moser M & Lunn J. Responses to captopril and hydrochlorothiazide in black patients with hypertension. Clin Pharmacol Ther 1982; 32: 307-12.
11. Cressman MD, Kosoglou T, Vlasses PH , Rocci ML, Mojaverian P, Earl G, Gabos C & Ferguson RK. Race influences the antihypertensive response to ketanserin (abstract). Clin Pharmacol Ther 1987; 41: 217.
12. Walle T, Byington RP, Furberg CD, McIntyre KM & Vokonas PS. Biological determinants of propranolol disposition: results from 1308 patients in the Beta-blocker Heart Attack Trial. Clin Pharmacol Ther 1985; 38: 509-18.
13. US Department of Health and Human Services, Public Health Service, National Institutes of Health. Inclusion of Women and Minorities in Study Populations: instruction and information. Bethesda, MD: US Department of Health and Human Services, Public Health Service, National Institutes of Health, 1990.
14. Gamble VN. A legacy of distrust: African Americans and medical research. Am J Prevent Med 1993; 9 (suppl 6): 35-8.
15. King PA. Twenty years after. The legacy of the Tuskegee Syphilis Study. The dangers of difference. Hastings Cent Rep 1992; 22: 35-38.
16. Sims JM. The Story of my Life. New York: Appleton, 1989: 236-7.
17. Adams E & Cowan G. The human guinea pig: how we test new drugs. World Magazine, 5 Dec 1972; 20-24.
18. Rothman DJ. Ethics and human experimentation Henry Beecher revisited. N Engl J Med 1987; 317: 1195-9.
19. Rosner F. The ethics of randomized clinical trials. Am J Med 1987; 82: 283-9.
20. Brown P & Concar D. Ethics report condemns "ignorant" AIDS researchers. New Scientist 1991; 27 July.
21. Welsh KA, Ballard E, Nash F, Raiford K & Harrell L. Issues affecting minority participation in research studies of Alzheimer disease. Alzheimer Dis Assoc Disord 1994; 8 (Suppl 4): 38-48.
22. Jones JH. The Tuskegee legacy, AIDS and the black community. Hastings Cent Rep 1992; 22: 38-40.
23. Bateman M, Kardinal CG, Lifsey D, Gralla RJ, Washington A, Scroggins T & Allen S. Barriers to minority recruitment: implications for chemoprevention trials (meeting abstract). Proc Ann Meet Am Soc Clin Oncol 1993; 12: A472.
24. Edgar H. Twenty years after. The legacy of the Tuskagee Syphilis Study. Outside the community. Hastings Cent Rep 1992; 22: 32-5.
25. Shafer JK, Usilton LJ & Gleeson GA. Untreated syphilis in the male Negro. Public Health Rep 1954; 69: 685-90.
26. Olansky S, Simpson L & Schuman SH. Environmental factors in the Tuskegee Study of untreated syphilis. Public Health Rep 1954; 69: 691-8.
27. Thomas SB & Quinn SC. The Tuskegee Syphilis Study, 1932 to 1972: implications for HIV education and AIDS risk education programs in the black community. Am J Public Health 1991; 81: 1498-505.
28. Small J. As quoted in Bates KG. Is it genocide? Essence 1990: 76.
29. Smith M. National Commission on AIDS, Hearings on HIV disease in African-American Communities, 1990. As quoted in Thomas SB & Quinn SC. The Tuskegee Syphilis Study, 1932 to 1972: implications for HIV education and AIDS risk education programs in the black community. Am J Public Health 1991; 81: 1499.
30. Flack J. As quoted in Byman B. Out from the shadow of Tuskegee. Fighting racism in medicine. Minn Med 1991; 74: 18.
31. Roberson NL. Clinical trial participation. Viewpoints from racial/ethnic groups. Cancer 1994; 74: 2687-91.
32. Caplan AL. Twenty years after. The legacy of the Tuskagee Syphilis Study. When evil intrudes. Hastings Cent Rep 1992; 22: 29-32.
33. Byman B. Out from the shadow of Tuskegee. Fighting racism in medicine. Minn Med 1991; 74: 15-20.
34. Brandt A. Racism and research: the case of the Tuskegee Syphilis Study. Hastings Cent Rep 1978; 8: 21-9.
35. Bates KG. Is it genocide? Essence 1990; 76-8, 116, 118.
36. Haywood LJ. Hypertension in minority populations, access to care. Am J Med 1990; 88 (Suppl 3B); 17-20S.
37. Minority Americans shortchanged on health care, survey shows (editorial). The Nation's Health. The American Public Health Association, 1995.
38. McCarthy CR. Historical background of clinical trials involving women and minorities. Acad Med 1994; 69: 695-8.
39. Blendon RJ, Scheck AC, Donelan K, Hill CA, Smith M, Beatrice D & Altman D. How white and African-Americans view their health and social problems. Different experiences, different expectations. JAMA 1995; 273: 341-6.
40. Valdivieso M, Kraut M, Wozniak A & Hussein M. Disease and socioeconomics, not bias, influence participation of lung cancer patients in clinical trials (meeting abstract). Proc Annu Meet Am Assoc Cancer Res 1993; 34: A1232.
41. Weddington WH, Gabel LL, Peet GM & Stewart SO. Quality of care and black American patients. J Natl Med Assoc 1992; 84: 569-75.
42. Perkfoff GT & Anderson M. Relationship between demographic characteristics, patient's chief complaint, and medical disposition in an emergency room. Med Care 1970; 8: 309-23.
43. Penchansky R & Fox D. Frequency of referral and patient characteristics in group practice. Med Care 1970; 8: 368-9.
44. Egbert LD & Rothman IL. Relation between the race and economic status of patients and who performs their surgery. N Engl J Med 1977; 297: 90-1.
45. Kjellstrand CM & Logan GM. Racial, sexual, and age inequalities in chronic dialysis. Nephron 1987; 45: 257-63.
46. Mayer WJ & McWhorter WP. Black/white differences in non-treatment of bladder cancer patients and implications for survival. Am J Public Health 1989; 79: 772-4.
47. Williams JF, Zimmerman JE & Wagner DP. African-American and white patients admitted to the intensive care unit: is there a difference in therapy and outcome? Crit Care Med 1995; 23: 626-36.
48. Office of the Inspector General. The Distribution of Organs for Transplantation: expectations and practices. Washington, DC. US Department of Health and Human Services, 1991.
49. Zachary AA. Is there racial bias in transplantation? J Natl Med Assoc 1993; 8: 821-3.
50. Held PJ, Pauly MV, Bovbjerg JD, Newmann J & Salvatierra O. Access to kidney transplantation. Has the United States eliminated income and racial differences? Arch Intern Med 1988; 148: 2594-600.
51. McBean AM, Warren JL & Babish JD. Continuing differences in the rates of percutaneous transluminal coronary angioplasty and coronary artery bypass graft surgery between elderly black and white Medicare beneficiaries. Am Heart J 1994; 127: 287-95.
52. Goldberg KC, Hartz AJ, Jacobsen SJ, Krakauer H & Rimm AA. Racial and community factors influencing coronary artery bypass graft surgery rates for all 1986 Medicare patients. JAMA 1992; 267: 1473-7.
53. Whittle J, Conigliaro J, Good CB & Lofgren RP. Racial differences in the use of invasive cardiovascular procedures in the Department of Veterans Affairs medical system. N Engl J Med 1993; 329: 621-7.
54. Kahn KL, Pearson JL, Harrison ER, Desmond KA, Rogers WH, Rubenstein LV, Brook RH & Keeler EB. Health care for black and poor hospitalized medicare patients. JAMA 1994; 271: 1169-74.
55. Hannan EL, Kilburn H, Donnell JF, Lukacik G & Shields EP. Interracial access to selected cardiac procedures for patients hospitalized with coronary artery disease in New York State. Med Care 1991; 29: 430-41.
56. Corin E. The cultural frame: context and meaning in the construction of health. In: Amick BC, Levine S, Tarlov AR & Walsh DC, Eds. Society and Health. New York: Oxford University Press, 1995; 272-304.
57. King G & Williams DR. Race and health: a multidimensional approach to African-American health. In: Amick BC, Levine S, Tarlov AR, Walsh DC Eds. Society and Health. New York: Oxford University Press, 1995: 93-130.
58. Patchter LM. Culture and clinical care-folk illness beliefs and behaviors and their implications for health care delivery. JAMA 1994; 271: 690-4.
59. Clark MM. Cultural context of medical practice. West J Med 1983; 139: 806-10.
60. Raya AE. Ethics and human experimentation: effect on cultural patterns and social values of Spanish surnamed Americans. Presented at the National Minority Conference on Human Experimentation, 1976.
61. Roberson MH. The influence of religious beliefs on health choices of Afro-Americans. Top Clin Nurs 1985; 7: 57-63.
62. Capers CF. Nursing and the Afro-American client. Top Clin Nurs 1985; 7: 11-17.
63. Kim SS. Ethnic elders and American health care - a physician's perspective. West J Med 1983; 139: 885-91.
64. Centers for Disease Control. Health beliefs, compliance - hypertension. JAMA 1990; 264: 2864.
65. Dresser R. Wanted single, white male for medical research. Hastings Cent Rep 1992; 22: 24-9.
66. Vollmer WM, Osborne ML, Hertert S & Buist AS. Recruiting hard-to-reach subjects: is it worth the effort? Control Clin Trials 1994; 15: 154-9.
67. Brown LS. Enrollment of drug abusers in HIV clinical trials: a public health imperative for communities of color. J Psychoactive Drugs 1993; 25: 45-52.
68. Clemmitt M. Clinical researchers adapting to mandate for more diversity in study populations. Scientist 1991; 5: 1-8.
69. Wermeling DP & Selwitz AS. Current issues surrounding women and minorities in drug trials. Ann Pharmacother 1993; 27: 904-10.
70. Kissinger P, Cohen D, Brandon W, Rice J, Morse A & Clark R. Compliance with public sector HIV medical care. J Natl Med Assoc 1995; 87: 19-24.
71. Psaty BM, Cheadle A, Koepsell TD, Diehr P, Wickizer T, Curry S, VonKorff M, Perrin EB, Pearson DC & Wagner EH. Race and ethnicity-specific characteristics of participants lost to follow-up in a telephone cohort. Am J Epidemiol 1994; 140: 161-71.
72. Pacy PJ, Dodson PM, Kubicki AJ, Fletcher RF & Taylor KG. High fibre, low sodium and low fat diet in white and black type 2 diabetics with mild hypertension. Diabetes Res 1986; 3: 287-92.
73. Gillium RF. American coronary primary prevention trials: implications for blacks. J Natl Med Assoc 1986; 78: 267-9.
74. Garrett TJ, Ashford A, Savage DG. Oncology clinic attendance at an inner city hospital. Cancer 1986; 58: 793-5.
75. Berg J & Berg BL. Compliance, diet, and cultural factors among black Americans with end-stage renal disease. J Natl Black Nurses Assoc 1989; 3: 16-28.
76. Traub YM, McDonald RH Jr & Shapiro AP. Patient characteristics and their influence on therapy and its outcome in hypertension of the elderly. Cardiology 1988; 75: 45-55.
77. Gregg J & Curry RH. Explanatory models for cancer among African-American women at two Atlanta neighborhood health centers: the implications for a cancer screening program. Soc Sci Med 1994; 39: 519-26.
78. Plawecki HM & Mallory DM. Compliance and health beliefs in the black female hypertensive client. J Natl Black Nurses Assoc 1987-1988; 2: 38-45.
79. Heurtin-Roberts S & Reisin E. The relation of culturally influenced lay models of hypertension to compliance with treatment. Am J Hypertens 1992; 5: 787-92.
80. Lucas CM. Compliance and illness responses. Top Clin Nurs 1986; 7: 47-56.
81. Neaton JD, Grimm RH Jr & Cutler JA for the MRFIT Research Group. Recruitment of participants for the Multiple Risk Factor Intervention Trial (MRFIT). Control Clin Trials 1987; 8: 41S-53S.
82. Johnson K & Arfken CL. Individual recruitment strategies in minority-focused research. In: Becker DM, Hill DR, Jackson JS, Levine DM, Stillman GA & Weiss SM, Eds. Health Behavior Research In Minority Populations: access, design and implementation. US Department of Health and Human Services. Public Health Service. National Institutes of Health. 1992: 24-29.
83. McGraw SA, McKinley JB, Crawford SA & Costa LA. Survey methods with minority populations, lessons from recent experience. Ethn Dis 1992; 2: 273-87.
84. Burish TG. Behavioral and psychosocial cancer research. Building on the past, preparing for the future. Cancer 1991; 67 (Suppl 3): 65-7.
85. Sheldon TA & Parker H. Race and ethnicity in health research. J Public Health Med 1992; 14: 104-10.
86. Swanson GM & Ward AJ. Recruiting minorities into clinical trials: toward a participant-friendly system. J Natl Cancer Inst 1995; 87: 1747-59.
87. Ahmed WIU, Kernohan EE & Baker MR. Health of British Asians: a research review. Commun Med 1989; 11: 49-56.
88. Comer JP. Research and the black backlash. Am J Orthopsychiat 1970; 40: 9-11.
89. Des Jarlais DC. History, ethics, and politics in AIDS prevention research. Am J Public Health 1991; 81: 1393-4.
90. Donovan JL. Ethnicity and health: a research review. Soc Sci Med 1984; 19: 663-70.
91. Morrow GR, Hickok JT & Burish TG. Behavorial aspects of clinical trials. An integrated framework from behavior theory. Cancer 1994; 74: 2676-82.
92. Nixon DW. Special aspects of cancer prevention trials. Cancer 1994; 74: 2683-6.
93. Friedman GD, Cutter GR, Donahue RP, Hughes GH, Hulley SB, Jacobs JR, DR, Liu K & Savage PJ. CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol 1988; 41: 1105-16.
94. Hughes GH, Cutter G, Donahue R, Friedman GD, Hulley S, Hunkeler E, Jacobs DR, Liu K, Orden S, Pierie P, Tucker B & Wagenknecht L. Recruitment in the Coronary Artery Disease Risk Development in Young Adults (CARDIA) Study. Control Clin Trials 1987; 4: 68S-73S.
95. Orden SR, Dyer AR & Kiu K. Recruiting young adults in an urban setting: the Chicago CARDIA experience. Am J Prevent Med 1990; 6: 176-82.
96. Ballard EI, Nash F, Raiford K & Harrell LE. Recruitment of black elderly for clinical research studies of dementia: the CERAD experience. Gerontologist 1993; 33: 561-5.
97. Gaston M, Smith J, Gallagher D, Flournoy-Gill Z, West S, Bellevue R, Farber M, Grover R, Koshy M, Richey AK, Williams J, Verter J & the CSSCD Study Group. Recruitment in the Cooperative Study of Sickle Cell Disease (CSSCD). Control Clin Trials 1987; 8: 131S-40S.
98. Kaluzny A, Brawley O, Garson-Angers D, Shaw J, Godley P, Warnecke R & Ford L. Assuring access to state of the art care for US minority populations: the first 2 years of the Minority-based Community Clinical Program. J Natl Cancer Inst 1993; 14: 104-10.
99. Ford CE, Langford HG & Palmer MJ. Recruitment in the Hypertension Detection and Follow-up Program. Control Clin Trials 1987; 8: 54S-67S.
100. Hypertension Detection and Follow-up Program Cooperative Group. Patient participation in a hypertension control program. JAMA 1978; 239: 1507-14.
101. Stoy DB, Curtis RC, Dameworth KS, Dowdy AA, Hegland J, Levin JA & Sousoulas BG. The successful recruitment of elderly black subjects in a clinical trial: the CRISP experience. J Natl Med Assoc 1995; 87: 280-7.
102. Sung JF, Coates RJ, Williams JE, Liff JM, Greenberg RS, McGrady GA, Avery AY & Blumenthal DS. Cancer screening intervention among black women in inner city Atlanta - design of a study. Public Health Rep 1992; 107: 361-8.
103. Croft JB, Webber LS, Parker LC & Berenson GS. Recruitment and participation of children in a long-term study of cardiovascular disease: the Bogalusa Heart Study, 1973-1982. Am J Epidemiol 1984; 120: 436-48.
104. Svensson CK. Representation of American blacks in clinical trials of new drugs. JAMA 1989; 262: 263-5.
105. Jonas H. Philisophical reflections on experimenting with human subjects. In: Freund PA, Ed. Experimentation with Human Subjects. New York: George Braziller, 1970: 1.
106. Toufexis A. Coming from a different place. Time 1990: 64-66. (Special issue on women.)
107. Dressler WW. Access issues and points of entry. In: Becker DM, Hill DR, Jackson JS, Levine DM, Stillman FA, Weiss SM, Eds. Health Behavior Research in Minority Populations: access, design, and implementation. US Department of Health and Human Services. Public Health Service. National Institutes of Health. 1992: 73-74.